白细胞介素-6阻断剂在类风湿关节炎的治疗应用

被引:18
作者
姜楠
费允云
赵岩
机构
[1] 中国医学科学院北京协和医学院北京协和医院内科
关键词
类风湿关节炎; 白细胞介素6; 托珠单抗;
D O I
暂无
中图分类号
R593.22 [类风湿性关节炎];
学科分类号
1002 ; 100201 ;
摘要
类风湿关节炎(rheumatoid arthritis,RA)是一种系统性炎症性自身免疫性疾病。免疫系统的失调在其发病中起着重要作用,因而抑制炎症反应是治疗RA的重要手段。白细胞介素6(interleukin-6,IL-6)是多功能细胞因子,与RA的发病有着密切联系。阻断IL-6信号传导通路是RA治疗的一个新策略。托珠单抗(Tocilizumab)是人源化IL-6受体单克隆抗体,一系列随机双盲安慰剂对照临床试验已显示其对于RA患者的疗效和安全性。这一药物可能会为RA的治疗带来新的曙光。
引用
收藏
页码:232 / 236
页数:5
相关论文
共 8 条
[1]  
Interleukin‐6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease‐modifying antirheumatic drugs: The tocilizumab in combination with traditional disease‐modifying antirheumatic drug therapy study[J] . Mark C.Genovese,James D.McKay,Evgeny L.Nasonov,Eduardo F.Mysler,Nilzio A.da Silva,EmmaAlecock,ThasiaWoodworth,Juan J.Gomez‐Reino.Arthritis & Rheumatism . 2008 (10)
[2]  
Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate[J] . Arthritis & Rheumatism . 2006 (9)
[3]   Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis [J].
Yokota, S ;
Miyamae, T ;
Imagawa, T ;
Katakura, S ;
Kurosawa, R ;
Mori, M .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (03) :231-237
[4]  
Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan[J] . Norihiro Nishimoto.Clinical Reviews in Allergy & Immunology . 2005 (3)
[5]   Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys [J].
Mihara, M ;
Kotoh, M ;
Nishimoto, N ;
Oda, Y ;
Kumagai, E ;
Takagi, N ;
Tsunemi, K ;
Ohsugi, Y ;
Kishimoto, T ;
Yoshizaki, K ;
Takeda, Y .
CLINICAL IMMUNOLOGY, 2001, 98 (03) :319-326
[6]   Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis [J].
Boe, A ;
Baiocchi, M ;
Carbonatto, M ;
Papoian, R ;
Serlupi-Crescenzi, O .
CYTOKINE, 1999, 11 (12) :1057-1064
[7]  
gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES[J] . Tetsuya Taga,Tadamitsu Kishimoto.Annual Review of Immunology . 1997
[8]  
lnterleukin-6 (IL-6) in Synovial Fluid and Serum of Patients with Rheumatic Diseases[J] . A. J. Swaak,A. Van Rooyen,E. Nieuwenhuis,L. A. Aarden.Scandinavian Journal of Rheumatology . 1988 (6)